These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 16164633)

  • 41. Is CD44 in glomerular parietal epithelial cells a pathological marker of renal function deterioration in primary focal segmental glomerulosclerosis?
    Froes BP; de Almeida Araújo S; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
    Pediatr Nephrol; 2017 Nov; 32(11):2165-2169. PubMed ID: 28799058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of early phenotypic change of glomerular podocytes detected by Pax2 in primary focal segmental glomerulosclerosis.
    Ohtaka A; Ootaka T; Sato H; Soma J; Sato T; Saito T; Ito S
    Am J Kidney Dis; 2002 Mar; 39(3):475-85. PubMed ID: 11877566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parietal Epithelial Cell Behavior and Its Modulation by microRNA-193a.
    Bharati J; Chander PN; Singhal PC
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The glomerular parietal epithelial cell's responses are influenced by SM22 alpha levels.
    Naito S; Pippin JW; Shankland SJ
    BMC Nephrol; 2014 Nov; 15():174. PubMed ID: 25376243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease.
    Smeets B; Stucker F; Wetzels J; Brocheriou I; Ronco P; Gröne HJ; D'Agati V; Fogo AB; van Kuppevelt TH; Fischer HP; Boor P; Floege J; Ostendorf T; Moeller MJ
    Am J Pathol; 2014 Dec; 184(12):3239-48. PubMed ID: 25307344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pathogenesis of focal segmental glomerulosclerosis.
    Jefferson JA; Shankland SJ
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):408-16. PubMed ID: 25168829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recognizing diversity in parietal epithelial cells.
    D'Agati VD; Shankland SJ
    Kidney Int; 2019 Jul; 96(1):16-19. PubMed ID: 31229027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Podocyte detachment and epithelial cell reaction in focal segmental glomerulosclerosis with cellular variants.
    Kihara I; Tsuchida S; Yaoita E; Yamamoto T; Hara M; Yanagihara T; Takada T
    Kidney Int Suppl; 1997 Dec; 63():S171-6. PubMed ID: 9407451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation.
    Bariéty J; Bruneval P; Hill G; Irinopoulou T; Mandet C; Meyrier A
    J Am Soc Nephrol; 2001 Feb; 12(2):261-274. PubMed ID: 11158216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Role of Platelet-Derived Growth Factor in Focal Segmental Glomerulosclerosis.
    Jia T; Xu T; Smeets B; Buhl EM; Moeller MJ; Floege J; Klinkhammer BM; Boor P
    J Am Soc Nephrol; 2023 Feb; 34(2):241-257. PubMed ID: 36351762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis.
    Asano T; Niimura F; Pastan I; Fogo AB; Ichikawa I; Matsusaka T
    J Am Soc Nephrol; 2005 Aug; 16(8):2257-62. PubMed ID: 15987751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.
    Zhang J; Pippin JW; Krofft RD; Naito S; Liu ZH; Shankland SJ
    Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1375-89. PubMed ID: 23486009
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parietal cells-new perspectives in glomerular disease.
    Miesen L; Steenbergen E; Smeets B
    Cell Tissue Res; 2017 Jul; 369(1):237-244. PubMed ID: 28361304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Podocalyxin-positive glomerular epithelial cells in urine correlate with a positive outcome in FSGS.
    Mueller-Deile J; Kümpers P; Achenbach J; Park JK; Mengel M; Haller H; Schiffer M
    J Nephrol; 2012; 25(5):802-9. PubMed ID: 22241637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Desmosomes as markers for the proliferating parietal epithelial cells in collapsing glomerulosclerosis. A case report.
    Mandache E; Stancu S; Ismail G; Penescu M
    Rom J Morphol Embryol; 2014; 55(2):459-62. PubMed ID: 24970002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The blind men and the elephant.
    Schwartz MM
    Kidney Int; 2005 Oct; 68(4):1894-5. PubMed ID: 16164669
    [No Abstract]   [Full Text] [Related]  

  • 57. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy.
    Barisoni L; Kriz W; Mundel P; D'Agati V
    J Am Soc Nephrol; 1999 Jan; 10(1):51-61. PubMed ID: 9890309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual lineage tracing shows that glomerular parietal epithelial cells can transdifferentiate toward the adult podocyte fate.
    Kaverina NV; Eng DG; Freedman BS; Kutz JN; Chozinski TJ; Vaughan JC; Miner JH; Pippin JW; Shankland SJ
    Kidney Int; 2019 Sep; 96(3):597-611. PubMed ID: 31200942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.
    Taneda S; Honda K; Ohno M; Uchida K; Nitta K; Oda H
    Virchows Arch; 2015 Oct; 467(4):449-58. PubMed ID: 26266776
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotypic change of glomerular podocytes in primary focal segmental glomerulosclerosis: developmental paradigm?
    Ohtaka A; Ootaka T; Sato H; Ito S
    Nephrol Dial Transplant; 2002; 17 Suppl 9():11-5. PubMed ID: 12386275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.